A detailed history of Aviva PLC transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Aviva PLC holds 211,315 shares of DGX stock, worth $29 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
211,315
Previous 201,975 4.62%
Holding current value
$29 Million
Previous $27.6 Million 4.79%
% of portfolio
0.08%
Previous 0.08%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$137.09 - $137.09 $1.28 Million - $1.28 Million
9,340 Added 4.62%
211,315 $29 Million
Q2 2024

Aug 02, 2024

BUY
$125.91 - $144.34 $5.81 Million - $6.66 Million
46,110 Added 29.58%
201,975 $27.6 Million
Q1 2024

May 14, 2024

BUY
$123.78 - $142.11 $5.74 Million - $6.59 Million
46,371 Added 42.35%
155,865 $20.7 Million
Q4 2023

Feb 09, 2024

SELL
$120.62 - $141.12 $7.38 Million - $8.63 Million
-61,160 Reduced 35.84%
109,494 $15.1 Million
Q3 2023

Nov 13, 2023

SELL
$121.86 - $144.92 $567,014 - $674,312
-4,653 Reduced 2.65%
170,654 $20.8 Million
Q2 2023

Aug 10, 2023

SELL
$130.56 - $146.84 $16.7 Million - $18.8 Million
-127,997 Reduced 42.2%
175,307 $24.6 Million
Q1 2023

May 12, 2023

BUY
$131.53 - $155.76 $15.1 Million - $17.8 Million
114,548 Added 60.69%
303,304 $42.9 Million
Q4 2022

Feb 09, 2023

BUY
$123.31 - $157.26 $7.15 Million - $9.12 Million
57,972 Added 44.33%
188,756 $29.5 Million
Q3 2022

Nov 14, 2022

BUY
$121.77 - $141.1 $2.07 Million - $2.4 Million
17,002 Added 14.94%
130,784 $16 Million
Q2 2022

Aug 04, 2022

BUY
$127.07 - $145.39 $5.81 Million - $6.65 Million
45,714 Added 67.16%
113,782 $15.1 Million
Q1 2022

May 13, 2022

BUY
$129.09 - $164.35 $1.59 Million - $2.02 Million
12,298 Added 22.05%
68,068 $9.32 Million
Q4 2021

Feb 10, 2022

BUY
$140.36 - $173.01 $1.07 Million - $1.32 Million
7,649 Added 15.9%
55,770 $9.65 Million
Q3 2021

Nov 12, 2021

BUY
$132.95 - $158.0 $598,275 - $711,000
4,500 Added 10.32%
48,121 $6.99 Million
Q2 2021

Aug 10, 2021

SELL
$126.66 - $141.48 $173,650 - $193,969
-1,371 Reduced 3.05%
43,621 $5.76 Million
Q1 2021

May 13, 2021

BUY
$114.63 - $133.34 $115,890 - $134,806
1,011 Added 2.3%
44,992 $5.77 Million
Q4 2020

Feb 10, 2021

BUY
$112.7 - $128.05 $73,029 - $82,976
648 Added 1.5%
43,981 $5.24 Million
Q3 2020

Nov 12, 2020

SELL
$107.05 - $130.01 $110,261 - $133,910
-1,030 Reduced 2.32%
43,333 $4.96 Million
Q2 2020

Aug 13, 2020

SELL
$73.34 - $122.61 $3.39 Million - $5.66 Million
-46,181 Reduced 51.0%
44,363 $5.06 Million
Q1 2020

May 14, 2020

BUY
$75.14 - $115.68 $1.92 Million - $2.96 Million
25,590 Added 39.4%
90,544 $7.27 Million
Q4 2019

Feb 10, 2020

BUY
$100.29 - $107.99 $1.78 Million - $1.91 Million
17,728 Added 37.54%
64,954 $6.94 Million
Q3 2019

Nov 12, 2019

SELL
$97.85 - $107.42 $288,070 - $316,244
-2,944 Reduced 5.87%
47,226 $5.06 Million
Q2 2019

Jul 30, 2019

SELL
$85.18 - $101.94 $93,357 - $111,726
-1,096 Reduced 2.14%
50,170 $5.11 Million
Q1 2019

May 14, 2019

BUY
$80.68 - $89.92 $32,756 - $36,507
406 Added 0.8%
51,266 $4.61 Million
Q4 2018

Feb 12, 2019

SELL
$79.75 - $108.38 $2.15 Million - $2.93 Million
-27,002 Reduced 34.68%
50,860 $4.24 Million
Q3 2018

Nov 13, 2018

SELL
$105.42 - $114.99 $314,151 - $342,670
-2,980 Reduced 3.69%
77,862 $8.4 Million
Q2 2018

Aug 01, 2018

SELL
$97.35 - $113.14 $81,579 - $94,811
-838 Reduced 1.03%
80,842 $8.89 Million
Q1 2018

May 14, 2018

SELL
$96.42 - $107.88 $710,615 - $795,075
-7,370 Reduced 8.28%
81,680 $8.19 Million
Q4 2017

Feb 13, 2018

SELL
$90.86 - $100.24 $985,194 - $1.09 Million
-10,843 Reduced 10.85%
89,050 $8.77 Million
Q3 2017

Nov 13, 2017

BUY
$91.96 - $108.35 $58,854 - $69,344
640 Added 0.64%
99,893 $9.35 Million
Q2 2017

Aug 07, 2017

BUY
N/A
99,253
99,253 $11 Million

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Aviva PLC Portfolio

Follow Aviva PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.